Effects of adiponectin on mortality and its mechanism in a sepsis mouse model

Journal of Investigative Surgery

Volumn 25, Issue 4, 2012, Pages 214-219

  Li, Sha ^a   Bao, Hong Guang ^a   Han, Liu ^a   Liu, Lele ^a   Wang, Xiaoliang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Anti inflammatory role; High mobility group protein 1; Interleukin 6; Survival curve; Tumor necrosis factor alpha

Indexed keywords

ADIPONECTIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM LIGATION AND PUNCTURE; CONTROLLED STUDY; LIGATION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PUNCTURE; SEPSIS;

ADIPONECTIN; ANIMALS; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; RNA, MESSENGER; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864581242     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2011.624257     Document Type: Article

References (29)

1. Opal SM, Fisher CJ, Jr, Dhainaut JF, et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo ontrolled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med. 1997;25:1115-1124.
2. Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 1995;273:934-941.
3. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63.
4. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Cin Chim Acta 2007;380(1-2):24-30.
5. Thakur V, PritchardMT, McMullenMR, et al. Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding.AmJ PhysiolGastrointest Liver Physiol. 2006;290:G998-G1007.
6. Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96: 1723-1732.
7. Wulster-Radcliffe MC, Ajuwon KM, Wang J, et al. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun. 2004; 316:924-929.
8. Uji Y, Yamamoto H, Tsuchihashi H, et al. Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. Surgery 2009;145:550-557.
9. Teoh H, Quan A, Bang KW, et al. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab. 2008;295:E658-E664.
10. Wang H, Yang H, Tracey KJ. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1768-1773.
11. Bustin M. Regulation of DNA dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999;19:5237-5246.
12. Yang H, Wang H, Czura CJ, et al. The cytokine activity of HMGB1. J Leukoc Biol. 2005;78:1-8.
13. Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta 2010;1799(1-2):149-156.
14. Chaudry IH, Wichterman KA, Baue AE. Effect of sepsis on tissue adenine nucleotide levels. Surgery 1979;85: 205-211.
15. Karantonis FF, Nikiteas N, Perrea D, et al. Evaluation of the effects of laparotomy and laparoscopy on the immune system in intra-abdominal sepsis-a review. J Invest Surg. 2008;21:330-339.
16. Freise H, Bruckner UB, Spiegel HU. Animal models of sepsis. J Invest Surg. 2001;14:195-212.
17. Peake PW, Shen Y, Campbell LV, et al. Human adiponectin binds to bacterial lipopolysaccharide. Biochem Biophys Res Commun. 2006;341:108-115.
18. Kuhns DB, Alvord WG, Gallin JI. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in human. J Infect Dis. 1995;171:145-152.
19. Damas P, Reuter A, Gysen P, et al. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 1989;17:975-978.
20. Remick DG, Bolgos GR, Siddiqui J, et al. Six at six: Interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 2002;17:463-467.
21. Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous highmobility group box 1. Proc Natl Acad Sci. 2004;101:296-301.
22. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285(5425):248-251.
23. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMGB1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192:565-570.
24. Shao YM, Yao HG, Liang XZ, et al. Relation between level of expression of high mobility group protein B1 in hepatic tissue with the severity and prognosis of sepsis in rats. Chinese Crit Care Med. 2006;18:668-672.
25. Wolf AM, Wolf D, Rumpold H, et al. Adiponectin induces tha anti-inflammatory cytokines IL-10 and IL- 1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323:630-635.
26. Tsuchihashi H, Yamamoto H, Maeda K, et al. Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis. J Surg Res. 2006;134:348-353.
27. Folco EJ, Rocha VZ, Lopez-llasaca M, et al. Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem. 2009;284: 25569-25575.
28. Huang H, Park PH, McMullen MR, et al. Mechanisms for the anti-inflammatory effects of adiponectin in macrophages. J Gastroenterol Hepatol. 2008;23(Suppl. 1):S50-S53.
29. Wolf AM,WolfD,Avila MA, et al. Up-regulation of the antiinflammatory adipokine adiponectin in acute liver failure in mice. J Hepatol. 2006;44:537-543.